BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19010770)

  • 1. Competitive repair pathways in immunoglobulin gene hypermutation.
    Reynaud CA; Delbos F; Faili A; Guéranger Q; Aoufouchi S; Weill JC
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):613-9. PubMed ID: 19010770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
    Gu X; Booth CJ; Liu Z; Strout MP
    Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concerted action of Msh2 and UNG stimulates somatic hypermutation at A . T base pairs.
    Frieder D; Larijani M; Collins C; Shulman M; Martin A
    Mol Cell Biol; 2009 Sep; 29(18):5148-57. PubMed ID: 19596785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of antibody somatic hypermutation.
    Di Noia JM; Neuberger MS
    Annu Rev Biochem; 2007; 76():1-22. PubMed ID: 17328676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacked DNA repair proteins and unchained DNA polymerases.
    Saribasak H; Rajagopal D; Maul RW; Gearhart PJ
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):605-11. PubMed ID: 19008198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases.
    Zanotti KJ; Gearhart PJ
    DNA Repair (Amst); 2016 Feb; 38():110-116. PubMed ID: 26719140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymerases and somatic hypermutation of immunoglobulin genes.
    Seki M; Gearhart PJ; Wood RD
    EMBO Rep; 2005 Dec; 6(12):1143-8. PubMed ID: 16319960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Ig gene hypermutation in Ung(-/-)Polh(-/-) mice suggests that UNG and A:T mutagenesis pathway target different U:G lesions.
    Li S; Zhao Y; Wang JY
    Mol Immunol; 2013 Mar; 53(3):214-7. PubMed ID: 22960197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rev1 is essential in generating G to C transversions downstream of the Ung2 pathway but not the Msh2+Ung2 hybrid pathway.
    Krijger PH; Tsaalbi-Shtylik A; Wit N; van den Berk PC; de Wind N; Jacobs H
    Eur J Immunol; 2013 Oct; 43(10):2765-70. PubMed ID: 23857323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
    Pilzecker B; Jacobs H
    Front Immunol; 2019; 10():438. PubMed ID: 30915081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UNG shapes the specificity of AID-induced somatic hypermutation.
    Pérez-Durán P; Belver L; de Yébenes VG; Delgado P; Pisano DG; Ramiro AR
    J Exp Med; 2012 Jul; 209(7):1379-89. PubMed ID: 22665573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T.
    Neuberger MS; Rada C
    J Exp Med; 2007 Jan; 204(1):7-10. PubMed ID: 17190841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing matters: error-prone gap filling and translesion synthesis in immunoglobulin gene hypermutation.
    Sale JE; Batters C; Edmunds CE; Phillips LG; Simpson LJ; Szüts D
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):595-603. PubMed ID: 19008194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic hypermutation: processivity of the cytosine deaminase AID and error-free repair of the resulting uracils.
    Storb U; Shen HM; Nicolae D
    Cell Cycle; 2009 Oct; 8(19):3097-101. PubMed ID: 19738437
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice.
    Xue K; Rada C; Neuberger MS
    J Exp Med; 2006 Sep; 203(9):2085-94. PubMed ID: 16894013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation.
    Rajagopal D; Maul RW; Ghosh A; Chakraborty T; Khamlichi AA; Sen R; Gearhart PJ
    J Exp Med; 2009 Jun; 206(6):1237-44. PubMed ID: 19433618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation.
    Diaz M; Lawrence C
    Trends Immunol; 2005 Apr; 26(4):215-20. PubMed ID: 15797512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic hypermutation: subverted DNA repair.
    Martomo SA; Gearhart PJ
    Curr Opin Immunol; 2006 Jun; 18(3):243-8. PubMed ID: 16616477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.
    Xiao Z; Ray M; Jiang C; Clark AB; Rogozin IB; Diaz M
    Mol Immunol; 2007 Apr; 44(10):2659-66. PubMed ID: 17240451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic hypermutation at A/T-rich oligonucleotide substrates shows different strand polarities in Ung-deficient or -proficient backgrounds.
    Zivojnovic M; Delbos F; Girelli Zubani G; Julé A; Alcais A; Weill JC; Reynaud CA; Storck S
    Mol Cell Biol; 2014 Jun; 34(12):2176-87. PubMed ID: 24710273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.